Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Laine

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Anti-Cancer Drug Design|January 5, 2002
A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38C Bailly, W Laine, B Baldeyrou, et al.
Chemical Research in Toxicology|February 15, 2001
DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cellsA Lansiaux, W Laine, B Baldeyrou, et al.
Biochemistry|April 11, 2001
DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogueJ F Goossens, E Bouey-Bencteux, R Houssin, et al.
Chemico-Biological Interactions|October 20, 2001
DNA interaction and cytotoxicity of a new series of indolo[2,3-b]quinoxaline and pyridopyrazino[2,3-b]indole derivativesP B Arimondo, B Baldeyrou, W Laine, et al.
Anti-Cancer Drug Design|October 26, 2000
DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepineC Bailly, W Laine, B Baldeyrou, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Anti-Cancer Drug Design|January 5, 2002
A novel B-ring modified homocamptothecin, 12-Cl-hCPT, showing antiproliferative and topoisomerase I inhibitory activities superior to SN-38C Bailly, W Laine, B Baldeyrou, et al.
Chemical Research in Toxicology|February 15, 2001
DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cellsA Lansiaux, W Laine, B Baldeyrou, et al.
Biochemistry|April 11, 2001
DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogueJ F Goossens, E Bouey-Bencteux, R Houssin, et al.
Chemico-Biological Interactions|October 20, 2001
DNA interaction and cytotoxicity of a new series of indolo[2,3-b]quinoxaline and pyridopyrazino[2,3-b]indole derivativesP B Arimondo, B Baldeyrou, W Laine, et al.
Anti-Cancer Drug Design|October 26, 2000
DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepineC Bailly, W Laine, B Baldeyrou, et al.
Pageof 2